In Australia, while successive governments have introduced policies and direct financial support for medical research and translation, none has been willing to acknowledge any relationship between PBS pricing and Australia's contribution to pharmaceutical innovation since the introduction of the 'Factor F' program in 1988.

Latest Video
New Stories
-
EBOS reports earnings growth as it prepares for Chemist Warehouse
February 21, 2019 - - Latest News -
MA: Where are the service standards and KPIs?
February 21, 2019 - - Latest News -
MA appoints two new board members
February 21, 2019 - - Latest News -
A nine month post-PBAC process?
February 21, 2019 - - Latest News -
What next for payment reform?
February 20, 2019 - - Latest News -
New report calls for greater focus on secondary CV events
February 20, 2019 - - Latest News -
Fee 'crunch' for smaller companies and patient populations
February 20, 2019 - - Latest News